By comparing the levels of pro-inflammatory cells between obese and non-obese CRC patients, it was revealed that the mean levels of IL-6, IL-4, and GM-CSF were significantly higher in obese CRC patients than that in non-obese patients [66, 67]. The gene discussed is CSF2; the disease is colorectal carcinoma.